Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia.

Hand NJ, Horner AM, Master ZR, Boateng LA, LeGuen C, Uvaydova M, Friedman JR.

J Pediatr Gastroenterol Nutr. 2012 Feb;54(2):186-92. doi: 10.1097/MPG.0b013e318244148b.

2.

Development and evaluation of a chromatographic procedure for partial purification of substance P with quantitation by an enzyme immunoassay.

Fehder WP, Ho WZ, Campbell DE, Tourtellotte WW, Michaels L, Cutilli JR, Uvaydova M, Douglas SD.

Clin Diagn Lab Immunol. 1998 May;5(3):303-7.

3.

Human monocytes and macrophages express substance P and neurokinin-1 receptor.

Ho WZ, Lai JP, Zhu XH, Uvaydova M, Douglas SD.

J Immunol. 1997 Dec 1;159(11):5654-60.

PMID:
9548509
4.

Substance P as an immune modulator of anxiety.

Fehder WP, Sachs J, Uvaydova M, Douglas SD.

Neuroimmunomodulation. 1997 Jan-Feb;4(1):42-8.

PMID:
9326744
5.

Substance P augments interleukin-10 and tumor necrosis factor-alpha release by human cord blood monocytes and macrophages.

Ho WZ, Kaufman D, Uvaydova M, Douglas SD.

J Neuroimmunol. 1996 Dec;71(1-2):73-80.

PMID:
8982105

Supplemental Content

Loading ...
Support Center